As of January 8 at 3:13:57 PM GMT+2. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ZAc.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Quinton Zunga B.Bus.Sci., MSc | MD, CEO & Executive Director | 3.4M | -- | 1978 |
| Ms. Aviwe Yondie Metu C.A. | CFO & Executive Director | 799.96k | -- | 1985 |
| Mr. Colin Wayne Clarke III, BA(Pol.Sc.), MBA | Chief Investment Officer & Executive Director | 2.8M | -- | 1967 |
RH Bophelo Limited
RH Bophelo
Unit 12, 1st floor 1 Melrose Boulevard Melrose Arch
Johannesburg, 2191
South Africa
- Sector:
- Healthcare
- Industry: Medical Care Facilities
Description
RH Bophelo Limited, together with its subsdidiaries, invests in the healthcare and financial sector in South Africa. It is involved in investment of equity, quasi-equity, and equity related investments in healthcare and financial services, primarily in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company was incorporated in 2016 and is based in Johannesburg, South Africa. RH Bophelo Limited is a subsidiary of Public Investment Corporation SOC Limited.
Corporate Governance
RH Bophelo Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 26, 2024 at 10:59 AM UTC
RH Bophelo Limited Earnings Date
Recent Events
December 12, 2023 at 12:00 AM UTC
Ex-Dividend Date